BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 16954130)

  • 21. [Effects of transcatheter closure of patent ductus arteriosus in 139 adult patients].
    Zhu XY; Chen HY; Zhang DZ; Han XM; Sheng XT; Cui CS; Zhang P; Wang QG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):998-1000. PubMed ID: 20137324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioptome-assisted coil occlusion of moderate-large patent ductus arteriosus in infants and small children.
    Kumar RK; Anil SR; Kannan BR; Philip A; Sivakumar K
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):266-71. PubMed ID: 15170724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure in 354 pediatric cases of patent ductus arteriosus using five different devices.
    Zhang Z; Qian M; Wang H; Li Y
    Chin Med J (Engl); 2001 May; 114(5):456-8. PubMed ID: 11780402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous treatment of moderate-to-large patent ductus arteriosus with different devices: early and mid-term results.
    Santoro G; Bigazzi MC; Carrozza M; Palladino MT; Sarubbi B; Scarpati C; Dalto M; Russo MG; Calabrò R
    Ital Heart J; 2005 May; 6(5):396-400. PubMed ID: 15934412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children.
    Thanopoulos B; Eleftherakis N; Tzannos K; Stefanadis C
    Am Heart J; 2008 Nov; 156(5):917.e1-917.e6. PubMed ID: 19061707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous transcatheter closure of patent ductus arteriosus with an amplatzer duct occluder using retrograde guidewire-established femoral arteriovenous loop.
    Zhang JF; Huang D; Yang YN; Gao XM; Ma YT
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):606-10. PubMed ID: 18177477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group.
    Gray DT; Fyler DC; Walker AM; Weinstein MC; Chalmers TC
    N Engl J Med; 1993 Nov; 329(21):1517-23. PubMed ID: 7695658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The percutaneous closure of the ductus arteriosus in adults].
    Anjos R; Menezes I; Martins FM
    Rev Port Cardiol; 1999 Mar; 18(3):255-9. PubMed ID: 10335089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter closure of patent ductus arteriosus.
    Shrivastava S; Marwah A; Radhakrishnan S
    Indian Pediatr; 2000 Dec; 37(12):1307-13. PubMed ID: 11119332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter closure of patent ductus arteriosus in Chinese adults: immediate and long-term results.
    Lee CH; Leung YL; Kwong NP; Kwok OH; Yip AS; Chow WH
    J Invasive Cardiol; 2003 Jan; 15(1):26-30. PubMed ID: 12499525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and safety of transcatheter intervention for complex patent ductus arteriosus.
    Yang SW; Zhou YJ; Hu DY; Liu YY; Shi DM; Guo YH; Cheng WJ; Nie XM; Wang JL
    Angiology; 2010 May; 61(4):372-6. PubMed ID: 19926620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder.
    Thanopoulos BD; Tsaousis GS; Djukic M; Al Hakim F; Eleftherakis NG; Simeunovic SD
    Heart; 2002 Mar; 87(3):260-3. PubMed ID: 11847167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous closure of a large PDA in a 35-year-old man with elevated pulmonary vascular resistance.
    Hokanson JS; Gimelli G; Bass JL
    Congenit Heart Dis; 2008; 3(2):149-54. PubMed ID: 18380767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results.
    Peirone A; Diaz J; Contreras A; Banille E; Cabrera M; Spillmann A; Bueno N; Juaneda E
    J Invasive Cardiol; 2011 Dec; 23(12):513-6. PubMed ID: 22147399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate- and long-term follow-up of device closure of patent arterial duct with severe pulmonary hypertension: factors predicting outcome.
    Sadiq M; Rehman AU; Hyder N; Qureshi AU; Kazmi T; Qureshi SA
    Cardiol Young; 2017 Jan; 27(1):26-36. PubMed ID: 27133447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of transcatheter patent ductus arteriosus closure in small weight infants.
    Drighil A; Al Jufan M; Al Omrane K; Al Atta J; Al Omrani A; Al Fadley F
    J Interv Cardiol; 2012 Aug; 25(4):391-4. PubMed ID: 22574623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder.
    García-Montes JA; Camacho-Castro A; Sandoval-Jones JP; Buendía-Hernández A; Calderón-Colmenero J; Patiño-Bahena E; Zabal C
    Cardiol Young; 2015 Mar; 25(3):491-5. PubMed ID: 24555910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results.
    Pass RH; Hijazi Z; Hsu DT; Lewis V; Hellenbrand WE
    J Am Coll Cardiol; 2004 Aug; 44(3):513-9. PubMed ID: 15358013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter closure of coronary artery fistula in children.
    Xu L; Xu ZY; Jiang SL; Zheng H; Zhao SH; Ling J; Zhang GJ; Wu WH; Li SG; Hu HB
    Chin Med J (Engl); 2010 Apr; 123(7):822-6. PubMed ID: 20497671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children.
    Butera G; De Rosa G; Chessa M; Piazza L; Delogu A; Frigiola A; Carminati M
    Heart; 2004 Dec; 90(12):1467-70. PubMed ID: 15547030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.